Humana Inc. (NYSE:HUM) Receives Consensus Recommendation of “Hold” from Brokerages

Shares of Humana Inc. (NYSE:HUM) have been given an average rating of “Hold” by the thirty ratings firms that are presently covering the firm, Marketbeat reports. One investment analyst has rated the stock with a sell rating, fifteen have assigned a hold rating and fourteen have given a buy rating to the company. The average 12-month price objective among brokerages that have issued a report on the stock in the last year is $403.9130.

A number of equities analysts recently weighed in on the company. Evercore raised Humana from an “in-line” rating to an “outperform” rating and set a $480.00 price target for the company in a report on Wednesday, July 29th. Jefferies Financial Group raised Humana from a “buy” rating to a “buy” rating in a report on Wednesday, May 20th. HSBC cut Humana to a “hold” rating in a research report on Thursday, July 30th. Mizuho upped their target price on Humana from $335.00 to $390.00 and gave the stock an “outperform” rating in a research note on Monday, June 8th. Finally, The Goldman Sachs Group increased their target price on Humana from $158.00 to $195.00 and gave the company a “sell” rating in a research report on Thursday, April 30th.

Humana Stock Up 0.4%

HUM stock opened at $392.72 on Friday. Humana has a one year low of $163.11 and a one year high of $428.88. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.74 and a current ratio of 1.74. The firm’s fifty day moving average is $385.08 and its 200 day moving average is $287.78. The firm has a market cap of $47.16 billion, a PE ratio of 37.15, a P/E/G ratio of 2.23 and a beta of 0.72.

Humana (NYSE:HUM) last issued its quarterly earnings data on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share for the quarter, topping analysts’ consensus estimates of $7.27 by $0.34. Humana had a net margin of 0.88% and a return on equity of 11.20%. The business had revenue of $40.89 billion during the quarter, compared to the consensus estimate of $40.58 billion. During the same quarter in the prior year, the firm posted $6.27 earnings per share. The company’s revenue was up 26.2% compared to the same quarter last year. On average, research analysts forecast that Humana will post 9.12 EPS for the current year.

Hedge Funds Weigh In On Humana

Several hedge funds and other institutional investors have recently added to or reduced their stakes in HUM. Manning & Napier Advisors LLC acquired a new stake in shares of Humana in the second quarter worth approximately $1,412,000. Mitsubishi UFJ Asset Management Co. Ltd. grew its holdings in shares of Humana by 4.1% during the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 250,330 shares of the insurance provider’s stock worth $66,207,000 after buying an additional 9,960 shares in the last quarter. Sustainable Insight Capital Management LLC grew its holdings in shares of Humana by 23.7% during the fourth quarter. Sustainable Insight Capital Management LLC now owns 24,757 shares of the insurance provider’s stock worth $6,341,000 after buying an additional 4,740 shares in the last quarter. Pzena Investment Management LLC acquired a new stake in shares of Humana in the second quarter valued at about $1,749,014,000. Finally, Swedbank AB lifted its stake in shares of Humana by 6.2% in the fourth quarter. Swedbank AB now owns 111,803 shares of the insurance provider’s stock worth $28,636,000 after buying an additional 6,534 shares in the last quarter. 92.38% of the stock is owned by hedge funds and other institutional investors.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.